A Study of LY4065967 in Healthy Japanese Participants

NCT06594159 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY4065967
DRUG: Placebo
DRUG: Rosuvastatin

Sponsor

Eli Lilly and Company